Troubleshooting Complications of Vascular Access Devices
The use of intravascular (IV) drugs and fluids has increased significantly in the past three decades due to their proven effectiveness in treating a wide array of diseases. This treatment modality necessitates long-term use of vascular access devices (VADs); however, maintaining vascular access throughout the course of treatment can be a challenge. Serious complications may develop or treatment delayed if vascular access cannot be maintained. Phlebitis and extravasation are other potential complications when smaller, more fragile blood vessels are used. Treatment often becomes a painful, dreaded ordeal especially for patients with limited or damaged blood vessels.
Genetic Modification Therapies – Clinical Applications & Technology Platforms
Genetic modification therapies are changing the landscape of medicine. These advanced therapies have the unprecedented ability to offer a one-time cure for severe, debilitating diseases that were previously untreatable. BCC Research found that this industry is segmented by technology platform, delivery method (viral versus nonviral), and clinical application. This specialization enables companies to build significant barriers to entry and competitive advantage.